NCT05611216View on ClinicalTrials.gov

Clinical Outcomes of 3L+ Therapies Among Patients With Chronic Myeloid Leukemia and Those With T315I Mutation

CompletedOBSERVATIONAL
Enrollment

164

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

December 23, 2021

Study Completion Date

December 23, 2021

Conditions
Chronic Myeloid Leukemia
Trial Locations (1)

07936

Novartis Investigative Site, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY